About Omniome
Omniome is a company based in San Diego (United States) founded in 2013 was acquired by PacBio in July 2021. Omniome has raised $160.23 million across 7 funding rounds from investors including PacBio, Gates Foundation and Arch Venture Partners. The company has 164 employees as of December 31, 2022. Omniome operates in a competitive market with competitors including Nanopore, PacBio, Complete Genomics, QuantuMDx and Bionano, among others.
- Headquarter San Diego, United States
- Employees 164 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Omniome, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Omniome
Unlock access to complete
Unlock access to complete
Funding Insights of Omniome
Omniome has successfully raised a total of $160.23M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $60 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Omniome
Omniome has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include PacBio, Gates Foundation and Arch Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science and technology sectors
|
Locked | Locked | Locked |
Investor details for Omniome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Omniome
Investment portfolio details for Omniome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Omniome
Detailed financials for Omniome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Omniome Comparisons
Peer comparison for Omniome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Omniome
Omniome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Complete Genomics, QuantuMDx and Bionano, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Provider of genome analysis solutions to researchers and clinicians
|
Detailed competitors of Omniome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Omniome
Complete news archive for Omniome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omniome
Omniome was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Omniome is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Dave Mullarkey is the current CEO of Omniome.
Omniome is a funded company, having raised a total of $160.23M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Omniome is 164.
Omniome was founded in 2013 and is headquartered in San Diego, United States. The company operates in the biotechnology sector, offering a genome sequencing platform based on Sequencing By Binding (SBB) technology. This platform supports nucleotide and DNA matching for clinical samples, with applications in cancer diagnostics, single-cell sequencing, and analysis of genome regions susceptible to errors. Services are extended to various clinical sequencing needs.
Omniome's top competitors include Nanopore, PacBio and Novogene Corporation.
Omniome has 13 investors. Key investors include PacBio, Gates Foundation, Arch Venture Partners, Detong Capital, and Decheng Capital.